+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Wound Biologics Market Research Report by Product (Growth Factors and Skin Substitutes), by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4989966
  • Report
  • July 2021
  • Region: Global
  • 191 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Wound Biologics Market will Grow to USD 7,406.64 Million by 2026, at a CAGR of 10.65%

FEATURED COMPANIES

  • Anika Therapeutics, Inc
  • ConvaTec Group PLC
  • Kerecis hf
  • Mimedx Group
  • Molnlycke Health Care AB
  • Nuo Therapeutics, Inc.
The Global Wound Biologics Market size was estimated at USD 4,034.31 Million in 2020 and expected to reach USD 4,450.55 Million in 2021, at a Compound Annual Growth Rate (CAGR) 10.65% to reach USD 7,406.64 Million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Wound Biologics to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the Wound Biologics Market was studied across Growth Factors and Skin Substitutes.
  • Based on Region, the Wound Biologics Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Wound Biologics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Wound Biologics Market, including Anika Therapeutics, Inc, Avita Medical, ConvaTec Group PLC, Cytori Therapeutics, Inc, Integra LifeSciences Holdings Corporation, Johnson & Johnson Services Inc., Kerecis hf, Leap Therapeutics, Marine Polymer Technologies Inc., Mimedx Group, Misonix, Inc., Molnlycke Health Care AB, Mylan N.V., Nuo Therapeutics, Inc., Organogenesis Inc., Skye Biologics, Inc., Smith & Nephew PLC, The 3M Company, Vericel Corporation, and Wright Medical Group, Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Wound Biologics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Wound Biologics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Wound Biologics Market?
4. What is the competitive strategic window for opportunities in the Global Wound Biologics Market?
5. What are the technology trends and regulatory frameworks in the Global Wound Biologics Market?
6. What is the market share of the leading vendors in the Global Wound Biologics Market?
7. What modes and strategic moves are considered suitable for entering the Global Wound Biologics Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Anika Therapeutics, Inc
  • ConvaTec Group PLC
  • Kerecis hf
  • Mimedx Group
  • Molnlycke Health Care AB
  • Nuo Therapeutics, Inc.
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Region Outlook
3.5. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidences of burn injuries in developing and underdeveloped regions
5.1.1.2. Increasing geriatric population globally
5.1.1.3. Government initiatives regarding wound care treatment in Europe and North America
5.1.2. Restraints
5.1.2.1. High cost of wound treatment
5.1.3. Opportunities
5.1.3.1. Innovations in wound care biologics in North America
5.1.3.2. Growing demand for bioengineered skin and substitutes in surgeries
5.1.4. Challenges
5.1.4.1. Lack of trained physicians in underdeveloped economies
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Wound Biologics Market, by Product
6.1. Introduction
6.2. Growth Factors
6.3. Skin Substitutes

7. Americas Wound Biologics Market
7.1. Introduction
7.2. Argentina
7.3. Brazil
7.4. Canada
7.5. Mexico
7.6. United States

8. Asia-Pacific Wound Biologics Market
8.1. Introduction
8.2. Australia
8.3. China
8.4. India
8.5. Indonesia
8.6. Japan
8.7. Malaysia
8.8. Philippines
8.9. Singapore
8.10. South Korea
8.11. Thailand

9. Europe, Middle East & Africa Wound Biologics Market
9.1. Introduction
9.2. France
9.3. Germany
9.4. Italy
9.5. Netherlands
9.6. Qatar
9.7. Russia
9.8. Saudi Arabia
9.9. South Africa
9.10. Spain
9.11. United Arab Emirates
9.12. United Kingdom

10. Competitive Landscape
10.1. FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. Market Ranking Analysis
10.3. Market Share Analysis, By Key Player
10.4. Competitive Scenario
10.4.1. Merger & Acquisition
10.4.2. Agreement, Collaboration, & Partnership
10.4.3. New Product Launch & Enhancement
10.4.4. Investment & Funding
10.4.5. Award, Recognition, & Expansion

11. Company Usability Profiles
11.1. Anika Therapeutics, Inc
11.2. Avita Medical
11.3. ConvaTec Group PLC
11.4. Cytori Therapeutics, Inc
11.5. Integra LifeSciences Holdings Corporation
11.6. Johnson & Johnson Services Inc.
11.7. Kerecis hf
11.8. Leap Therapeutics
11.9. Marine Polymer Technologies Inc.
11.10. Mimedx Group
11.11. Misonix, Inc.
11.12. Molnlycke Health Care AB
11.13. Mylan N.V.
11.14. Nuo Therapeutics, Inc.
11.15. Organogenesis Inc.
11.16. Skye Biologics, Inc.
11.17. Smith & Nephew PLC
11.18. The 3M Company
11.19. Vericel Corporation
11.20. Wright Medical Group, Inc.

12. Appendix
12.1. Discussion Guide
12.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL WOUND BIOLOGICS MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 3. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY REGION, 2020 (USD MILLION)
FIGURE 4. GLOBAL WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 5. GLOBAL WOUND BIOLOGICS MARKET: MARKET DYNAMICS
FIGURE 6. GLOBAL WOUND BIOLOGICS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 7. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 8. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2026
FIGURE 10. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, 2018-2026 (USD MILLION)
FIGURE 11. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 12. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2026 (USD MILLION)
FIGURE 13. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 14. AMERICAS WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 15. ARGENTINA WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 16. BRAZIL WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 17. CANADA WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 18. MEXICO WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 19. UNITED STATES WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 20. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 21. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 22. CHINA WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 23. INDIA WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 24. INDONESIA WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 25. JAPAN WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 26. MALAYSIA WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 27. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 28. SINGAPORE WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 29. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 30. THAILAND WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 31. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 32. FRANCE WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 33. GERMANY WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 34. ITALY WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 35. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 36. QATAR WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 37. RUSSIA WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 38. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 39. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 40. SPAIN WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 41. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 42. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 43. GLOBAL WOUND BIOLOGICS MARKET: FPNV POSITIONING MATRIX
FIGURE 44. GLOBAL WOUND BIOLOGICS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 45. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL WOUND BIOLOGICS MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL WOUND BIOLOGICS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY SKIN SUBSTITUTES, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. AMERICAS WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 8. ARGENTINA WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 9. BRAZIL WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 10. CANADA WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 11. MEXICO WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 13. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 14. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 15. CHINA WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 16. INDIA WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 17. INDONESIA WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 18. JAPAN WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 19. MALAYSIA WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 20. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 21. SINGAPORE WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 22. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 23. THAILAND WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. FRANCE WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. GERMANY WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. ITALY WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. QATAR WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. RUSSIA WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. SPAIN WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. GLOBAL WOUND BIOLOGICS MARKET: SCORES
TABLE 37. GLOBAL WOUND BIOLOGICS MARKET: BUSINESS STRATEGY
TABLE 38. GLOBAL WOUND BIOLOGICS MARKET: PRODUCT SATISFACTION
TABLE 39. GLOBAL WOUND BIOLOGICS MARKET: RANKING
TABLE 40. GLOBAL WOUND BIOLOGICS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 41. GLOBAL WOUND BIOLOGICS MARKET: MERGER & ACQUISITION
TABLE 42. GLOBAL WOUND BIOLOGICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 43. GLOBAL WOUND BIOLOGICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 44. GLOBAL WOUND BIOLOGICS MARKET: INVESTMENT & FUNDING
TABLE 45. GLOBAL WOUND BIOLOGICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 46. GLOBAL WOUND BIOLOGICS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Anika Therapeutics, Inc
  • Avita Medical
  • ConvaTec Group PLC
  • Cytori Therapeutics, Inc
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services Inc.
  • Kerecis hf
  • Leap Therapeutics
  • Marine Polymer Technologies Inc.
  • Mimedx Group
  • Misonix, Inc.
  • Molnlycke Health Care AB
  • Mylan N.V.
  • Nuo Therapeutics, Inc.
  • Organogenesis Inc.
  • Skye Biologics, Inc.
  • Smith & Nephew PLC
  • The 3M Company
  • Vericel Corporation
  • Wright Medical Group, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll